Hypertension Scientific Sessions 2023

September 7–10, 2023
Sheraton Boston Hotel | Boston, Massachusetts

Attendees introduce themselves during a coffee break at Hypertension 2022.

Make new connections at #Hypertension23

Mark your calendar:
September 7–10, 2023
Sheraton Boston Hotel | Boston, Massachusetts

#Hypertension23

Abstract submission is now closed.

Join us at one of the most important medical meetings about hypertension in the world, with experts in the fields of hypertension and its relationship to cardiac and kidney disease, stroke, obesity and genetics. Oral and poster presentations, cross-disciplinary connections, sessions for early-career and trainees, clinical science and practice, primary care programming: there’s a lot here for you!

Announcing the 2023 Keynote Speaker

Mario R. Capecchi, PhD, FAHA Hypertension 2023
Opening Keynote Lecture
Mario R. Capecchi, PhD
University of Utah School of Medicine
Distinguished Professor Human Genetic and Biology
Adjunct Professor Oncological Sciences
Winner, 2007 Nobel Prize in Physiology or Medicine

Dr. Capecchi is known for his pioneering work on the development of gene targeting in mice. This technology allows creation of mutations in any desired gene, providing virtually complete freedom to manipulate the genome of living mice. His work has revolutionized the study of mammalian biology and is used to understand countless diseases by scientists worldwide. In 2007, he was recognized for this achievement with the Nobel Prize in physiology or medicine.

His current research is directed at determining the molecular mechanism responsible for chronic anxiety and obsessive-compulsive disorders.

Hypertension 2023 Executive Committee

CHAIR
R. Ariel Gomez, MD, FAHA
University of Virginia

INCOMING CHAIR
Jane F. Reckelhoff, PhD, FAHA
University of Mississippi Medical Center

CLINICAL CHAIR
Wanpen Vongpatanasin, MD, FAHA
UT Southwestern
Dallas, TX

VICE-CHAIR
Alexander Staruschenko, PhD, FAHA
University of South Florida

INCOMING VICE-CHAIR
Thu Le, MD, FAHA
University of Rochester

Program Committee Members

Curt Sigmund, PhD, FAHA (ex-officio)
Cameron McCarthy, PhD, FAHA (Liaison, Trainee Advocacy Committee)
Christopher Banek, PhD
David Ellison, MD
Yumei Feng, MD, PhD, FAHA
Karen Griffin, MD, FAHA
Justin Grobe, PhD, FAHA
Eric Lazartigues, PhD, FAHA

Cameron McCarthy, PhD Liaison, Trainee Advocacy Committee
Gary Schwartz, MD
Richard Wainford, PhD
Stephanie Watts, PhD, FAHA
R Clinton Webb, PhD, FAHA
Camilla Wenceslau, PhD, MS, FAHA
Brandi Wynne, MS, PhD, FAHA

Clinical Practice/Clinical Science Program Subcommittee

Meena Madhur, MD, PhD, FACC, FAHA
Vanderbilt University Medical Center
Co-Chair

Natalie Bello, MD, MPH, FACC
Cedars Sinai
Co- Chair

Marwah Abdalla, MD
George Bakris, MD
Nisha Bansal MD, MAS
Jan Basile, MD
Jennifer Brown, MD
Robert M. Carey, MD, MACP, FRCP, FRCPI, FAHA
John Dodson, MD, MPH
William Elliott, MD. PhD
Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA

Lama Ghazi, MD, PhD
Karen A. Griffin, M., FAHA, FASN, FACP
Alan L. Hinderliter, MD
Luke Laffin, MD
James M. Luther, MD, MSCI
Raj Padwal, MD
Kristi Reynolds, PhD, MPH, FAHA, FACE
Benjamin M. Scirica, MD, MPH
Elaine Urbina, MD, MS
Brandi Wynne, PhD, FAHA
Eugene Yang, MD, FACC

Primary Care Track Program Subcommittee

Stephen P. Juraschek, MD, PhD, FAHA, AHSCP-CHS
Harvard Medical School
Co-Chair

Valy Fontil, MD
NYU Langone Health
Co-Chair

Jan Basile, MD
Michael Bloch, MD
Shari Bolen, MD, MPH
Adam Bress, PharmD, MS
Alexander Chang, MD, MS
Jennifer Cluett, MD
Yvonne Commodore-Mensah, PHD, MHS, RN
Rhonda Cooper-DeHoff, PharmD, MS
Dave L. Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS

Brent Egan, MD
Naomi Fisher, MD
Beverly B. Green, MD, MPH
Ian Kronish, MD, MPH
Aisha Langford, MPH, PhD
Joshua Samuels, MD, MPH
Anthony Viera, MD
Hilary K. Wall, MPH
Steven A Yarows, MD, FACP, FASH

Why You Should Attend Hypertension Scientific Sessions

Considered one of the most important medical meetings on this subject in the world, the conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions led by leading authorities. With experts in the fields of hypertension and its relationship to cardiac and kidney disease, stroke, obesity, and genetics, attendees will have the opportunity to connect with cross-disciplinary researchers from around the world.

This meeting also offers sessions specifically designed to benefit trainees and early career investigators, as well as Clinical Practice Clinical Science topics focused on applying clinical science to the clinician’s practice and Primary Care programming dedicated to practical advice for the Primary Care Provider (PCP) interested in clinical hypertension.